TCR β-Chain Variable Region-Driven Selection and Massive Expansion of HLA-Class I-Restricted Antitumor CTL Lines from HLA-A*0201+ Melanoma Patients

Journal of Immunology

Volumn 158, Issue 12, 1997, Pages 5902-5913

  Maccalli, Cristina ^a   Farina, Cinthia ^a   Sensi, Marialuisa ^a   Parmiani, Giorgio ^a   Anichini, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY;

ARTICLE; CELL LINE; CYTOTOXIC T LYMPHOCYTE; GENE; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; MELANOMA; MIXED LYMPHOCYTE CULTURE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; CELL LINE; EPITOPES; GENES, MHC CLASS I; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE CULTURE TEST, MIXED; MELANOMA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031570446     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Clark, W. H. 1991. Tumor progression and the nature of cancer. Br. J. Cancer 64:631.
2. Clemente, C. G., M. C. Mihm, Jr., R. Bufalino, S. Zurrida, P. Collini, and N. Cascinelli. 1996. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary (AJCC stage I) cutaneous melanoma. Cancer 77:1303.
3. Crowley, N. J., T. L. Darrow, M. A. Quinn-Allen, and H. F. Seigler. 1991. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T-cells: evidence for restriction by a dominant HLA-A allele. J. Immunol. 146: 1692.
4. Sensi, M. L., and G. Parmiani. 1995. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today 16: 588.
5. Sensi, M. L., S. Salvi, C. Castelli, C. Maccalii, A. Mazzocchi, R. Mortarini, G. Nicolini, M. Herlyn, G. Parmiani, and A. Anichini. 1993. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocytes overexpress in vivo the TCR β chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. J. Exp. Med. 178:1231.
6. Ferradini, L., A. Mackensen, C. Genevee, J. Bosq, P. Duvillard, M.-F. Avril, and T. Hercend. 1993. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a regressive melanoma. J. Clin. Invest. 91:1183.
7. Mackensen, A., G. Carcelain, S. Viel, M.-C. Raynal, H. Michalaki, F. Triebel, J. Bosq, and T. Hercend. 1994. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest. 93:1397.
8. Anichini, A., C. Maccalli, R. Mortarini, S. Salvi, A. Mazzocchi, P. Squarcina, M. Herlyn, and G. Parmiani. 1993. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J. Exp. Med. 177:989.
9. Salvi, S., F. Segalla, S. Rao, F. Arienti, M. Sartori, G. Bratina, E. Caronni, A. Anichini, C. Clemente, G. Parmiani, and M. L. Sensi. 1995. Overexpression of the T-cell receptor β-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer Res. 55:3374.
10. Anichini, A., R. Mortarini, C. Maccalli, P. Squarcina, K. Fleischhauer, L. Mascheroni, and G. Parmiani. 1996. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A*0201-restricted immune repertoire to melanoma. J. Immunol. 156:208.
11. Russo, C., A. K. Ng, M. A. Pellegrino, and S. Ferrone. 1983. The monoclonal antibody CR11.351 discriminates HLA-A2 variants identified by T cells. Immunogenetics 18:23.
12. Young Yang, S., Y. Morishima, N. H. Collins, T. Alton, M. S. Pollack, E. J. Yunis, and B. Dupont. 1984. Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes. Immunogenetics 19:217.
13. Baroja, M. L., K. Lorre, F. Van Vaeck, and J. L. Ceuppens. 1989. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens. Cell. Immunol. 120:205.
14. van Lier, R. A. W., M. Brouwer, V. I. Rebel, C. J. M. Van Noesel, and L. A. Aarden. 1989. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes. Immunology 68:45.
15. Robbins, P. F., and Y. Kawakami. 1996. Human tumor antigens recognized by T cells. Curr. Opin. Immunol. 8:628.
16. Genevée, C. M., A. Diu, J. Nierat, A. Caignard, P. Y. Dietrich, L. Ferrarini, S. Roman-Roman, F. Triebel, and T. Hercend. 1992. An experimentally validated panel of sub-family-specific oligonucleotide primers (Vα 1-w29/Vβ 1-w24) for the study of human T-cell-receptor variable V-gene segment usage by polymerase chain reaction. Eur. J. Immunol. 22:1261.
17. Williams, A. F., J. L. Strominger, J. Bell, T. W. Mak, J. Kappler, P. Marrack, B. Arden, M. P. Lefranc, L. Hood, S. Tonegawa, and M. Davis. 1995. Nomenclature for T-cell receptor (TCR) gene segments of the immune system. Immunogenetics 42:451.
18. Arden, B., S. P. Clark, D. Kabelitz, and T. W. Mak. 1995. Human T-cell receptor variable region segment families. Immunogenetics 42:455.
19. Moss, P. A. H., and J. I. Bell. 1995. Sequence analysis of the human alpha/beta T-cell receptor CDR3 region. Immunogenetics 42:10.
20. Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725.
21. Reinherz, E. L., S. Meuer, K. A. Fitzgerald, R. E. Hussey, H. Levine, and S. F. Schlossman. 1982. Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell 30:735.
22. lck in T-cell infiltrating human renal cell carcinoma. Cancer Res. 53:5613.
23. Farace, F., E. Angevin, J. Vanderplancke, B. Escudier, and F. Triebel. 1994. The decreased expression of CD3 ζ chains in cancer patients not reversed by IL-2 administration. Int. J. Cancer 59:752.
24. Sensi, M. L., C. Traversari, M. Radrizzani, S. Salvi, C. Maccalli, R. Mortarini, L. Rivoltini, C. Farina, G. Nicolini, T. Wolfel, V. Brichard, T. Boon, C. Bordignon, A. Anichini, and G. Parmiani. 1995. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/ Mart-1. Proc. Natl. Acad. Sci. USA 92:5674.
25. Lehmann, F., M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon, and P. G. Coulie. 1995. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340.
26. Cole, D. J., D. P. Weil, P. Shamamian, L. Rivoltini, Y. Kawakami, S. Topalian, C. Jennings, S. Eliyahu, S. A. Rosenberg, and M. I. Nishimura. 1994. Identification of MART-1 specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res. 54:5265.
27. Puisieux, I., C. Bain, Y. Merrouche, P. Malacher, P. Kourilsky, J. Even, and M. Favrot. 1996. Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma: relevance of the CDR3 length analysis for the identification of in-situ clonal T-cell expansions. Int. J. Cancer 66:201.
28. Farace, F., F. Orlanducci, P.-Y. Dietrich, C. Gaudin, E. Angevin, M.-H. Courtier, C. Bayle, T. Hercend, and F. Triebel. 1994. T cell repertoire in patient with B chronic lymphocytic leukemia: evidence for multiple in vivo T cell clonal expansion. J. Immunol. 153:4281.
29. Prevost-Blondel, A., M. Ostankovitch, J. Melle., C. Pannetier, E. Macintyre, F. Dreyfus, and J.-G. Guillet. 1995. CDR3 size analysis of T cell receptor V beta transcripts: follow-up study in a patient with T cell acute lymphoblastic leukemia. Leukemia 9:1711.
30. Kluin-Nelemans, J. C., M. G. D. Kester, J. . J. Melenhorst, J. E. Landegent, L. van de Corput, R. Willemze, and J. H. F. Falkenburg. 1996. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 87:3795.
31. McHeyzer, M. G., and M. K. Davis. 1995. Antigen-specific development of primary and memory T cells in vivo. Science 268:106.
32. Gervois, N., Y. Guiloux, E. Diez, and F. Jotereau. 1996. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interaction. J. Exp. Med. 183:2403.
33. Alkolkar, P., N. B. Gulwani-Alkolkar, R. Pergolizzi, R. D. Bigler, and J. Silver. 1993. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J. Immunol. 150:2761.
34. Bonfert, V., J. Cihak, U. Losch, and H. W. L. Ziegler-Heitbrock. 1995. Preferential expression of Vβ gene families in CD8 memory cells of apparently healthy donors. Cell. Immunol. 166:165.